Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Hiroya Fujioka"'
Autor:
Yuki Otsuki, MD, PhD, Takashi Nuri, MD, PhD, Masashi Okada, MD, PhD, Koichi Ueda, MD, PhD, Hiroya Fujioka, MD, PhD, Kosei Kimura, MD, PhD, Mitsuhiko Iwamoto, MD, PhD
Publikováno v:
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9, p e1920 (2018)
Summary:. A case of advanced breast carcinoma with large skin invasion that extended from the breast to the axilla and which was reconstructed with a meshed split skin graft for the chest defect and a posterior circumflex humeral artery perforator fl
Externí odkaz:
https://doaj.org/article/2f7e700bd1364e6abbcef90f7a3350f5
Autor:
Hiroshi Kawasaki, Shintarou Shigesato, Wataru Osumi, Kanji Nishiguchi, Masao Toyoda, Hiroya Fujioka, Kazuhisa Uchiyama
Publikováno v:
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons). 43:823-831
Autor:
HIROYA FUJIOKA1, AKIKO SAKAI2 asakai77777@gmail.com, SATORU TANAKA1, KOSEI KIMURA1, AKIKO MIYAMOTO1, MITSUHIKO IWAMOTO1, KAZUHISA UCHIYAMA1 uchi@osaka-med.ac.jp
Publikováno v:
Oncology Letters. Jan2017, Vol. 13 Issue 1, p289-295. 7p.
Autor:
Kanako Kawaguchi, Hiroya Fujioka, Kosei Kimura, Yoshihumi Narumi, Risa Terasawa, Mitsuhiko Iwamoto, Izumi Morinaga, Yoshitaka Kurisu, Erika Hattori, Masako Yuki, Kazuhisa Uchiyama
Publikováno v:
Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 26:195-199
Autor:
Nayuko Sato, Kosei Kimura, Yuka Asano, Yukihiro Nishida, Shinichiro Kashiwagi, Tsutomu Takashima, Takashi Morimoto, Ayana Ikari, Toshihiro Kobayashi, Satoru Noda, Yukie Tauchi, Hiroya Fujioka, Naofumi Oda, Mitsuhiko Iwamoto, Nobuki Matsunami, Satoru Tanaka, Risa Terasawa, Hirotaka Morishima, Junna Sakane, Kanako Kawaguchi, Toshikatsu Nitta, Norihiro Hokimoto, Shintaro Michishita
Publikováno v:
Cancer chemotherapy and pharmacology. 83(6)
Neoadjuvant trastuzumab combined with anthracycline and taxane is now considered a standard regimen for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. A less toxic, non-anthracycline regimen has been considered as a treatment
Autor:
Kanako Kawaguchi, Nayuko Sato, Hiroya Fujioka, Kazuhisa Uchiyama, Risa Terasawa, Junna Matsuda, Nodoka Umezaki, Kosei Kimura, Mitsuhiko Iwamoto, Satoru Tanaka
Publikováno v:
Molecular and Clinical Oncology. 5:385-390
The purpose of this study was to retrospectively analyze the feasibility of outpatient management without initial assessment for febrile patients undergoing adjuvant chemotherapy for breast cancer. A total of 131 consecutive patients with breast canc
Autor:
Kosei Kimura, Hiroya Fujioka, Takashi Nuri, Mitsuhiko Iwamoto, Koichi Ueda, Masashi Okada, Yuki Otsuki
Publikováno v:
Plastic and Reconstructive Surgery Global Open
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9, p e1920 (2018)
Plastic and Reconstructive Surgery, Global Open, Vol 6, Iss 9, p e1920 (2018)
Summary:. A case of advanced breast carcinoma with large skin invasion that extended from the breast to the axilla and which was reconstructed with a meshed split skin graft for the chest defect and a posterior circumflex humeral artery perforator fl
Autor:
Kosei Kimura, Takashi Morimoto, Mitsuhiko Iwamoto, Kanako Kawaguchi, Risa Terasawa, Hiroyuki Ogura, Nobuki Matsunami, Satoru Tanaka, Daigo Yamamoto, Katsuhide Yoshidome, Hiroya Fujioka, Toshikatsu Nitta, Kazuhisa Uchiyama, Yuko Takahashi
Publikováno v:
Cancer chemotherapy and pharmacology. 81(5)
Although eribulin is a suitable option for early-line treatment of metastatic breast cancer (MBC), data on first- or second-line use of eribulin for human epidermal growth factor receptor 2 (HER2)-negative MBC are still limited. Therefore, we conduct
Autor:
A. Hirata, A. Matsutani, Mitsuhiko Iwamoto, T. Tominaga, M. Nishida, Hiroya Fujioka, Kosei Kimura
Publikováno v:
The Breast. 44:S115
Autor:
Kosei Kimura, Kazuhisa Uchiyama, Hiroya Fujioka, Satoru Tanaka, Mitsuhiko Iwamoto, Yuko Takahashi, Nayuko Sato
Publikováno v:
The Breast Journal. 20:154-158
We evaluated the cosmetic outcome of volume replacement with oxidized regenerated cellulose (ORC) after breast-conserving surgery (BCS) and also examined factors that may have influenced the results. Ninety-four patients who underwent BCS with ORC re